The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Non-profit
  • Books
  • Technology
  • Entertainment

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics
The PennZone/10273770

Trending...
  • How AI Exposed Major Flaws in the Foundation & Structure of Technology, Hardware & the Internet & Phinge's® Patented Netverse®, App-less Solution
  • Only 7 Days Left for Early Bird Registration to the OpenSSL Conference 2025
  • Joint Venture for Expansion Into Asset-Backed Real Estate; $100 Million Initiative via Offering of Shares at Over $4 for Digital Assets: $OFAL
SAN DIEGO, June 17, 2024 ~ In a recent announcement, Primrose Bio, Inc. revealed that it has received a significant equity investment from 1315 Capital, a healthcare-focused growth equity firm based in Philadelphia. This investment will provide the necessary funds for the company to further develop and expand its three major offerings.

Primrose Bio, Inc., also known as "Primrose," is dedicated to developing and licensing manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines. With this new investment, the company is well-positioned to advance its solutions for therapeutic protein and nucleic acid manufacturing with both current and future partners.

One of Primrose's key offerings is Prima RNApols™, which are proprietary RNA polymerase enzymes that have been shown to significantly improve mRNA manufacturing. These enzymes have been found to increase yields by up to 5 times, eliminate double-stranded RNA, and enhance cap incorporation compared to the commonly used T7 RNA polymerase standard.

Another major offering from Primrose is Pfenex Expression Technology®, a validated microbial expression system that has been used in five approved drugs. This technology consistently demonstrates 10-20 times higher yields compared to other systems such as E.coli, CHO, and yeast-based systems. It also boasts an unparalleled success rate in producing complex proteins.

More on The PennZone
  • DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating data privacy Claims on Behalf of TransUnion Customers
  • Integris Composites Joins Pacific Future Forum in Tokyo
  • BusinessRate Selects New Jersey Therapy & Life Coaching as Best Couselors
  • IRL Investigations Combines Decades of Experience with Modern Digital Expertise
  • New Leadership Model – Never Fire Anyone – Released Today

Lastly, Primrose offers PeliCRM®, the only commercially available CRM197 conjugate vaccine carrier protein used in approved products. This technology plays a crucial role in the production of vaccines.

Dr. Helge Zieler, CEO of Primrose Bio, Inc., expressed excitement about the partnership with 1315 Capital. "We are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing technologies for the pharmaceutical industry," he said.

Matt Reber, Partner at 1315 Capital, also shared his enthusiasm for this collaboration. "There has been a tremendous amount of innovation in therapeutics over the last decades, and relatively little in their production systems," he stated. "Primrose's validated technology platforms address an increasingly important challenge facing the industry as drugs get more complex, and pricing pressure continues to mount."

With this new investment, Primrose Bio, Inc. is poised to make significant strides in the biomanufacturing industry and continue to provide cutting-edge solutions for therapeutic protein and nucleic acid manufacturing.
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
  • Costa Oil – 10 Minute Oil Change Opens 70th Location in Reed City, MI
  • New Book: Cold War Sci-Fi Thriller Arrives Today
  • BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
  • DEADLINE TOMORROW: Berger Montague Advises Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) Investors to Inquire About a Securities Fraud Class Action by August 29, 2025
  • University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
  • Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
  • Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
  • Growth Acceleration via Strategic Reverse Split After $10 Million Acquisition for Concerts.com and TicketStub.com; AI Powered Sports/Entertainment Co
  • Hollywood Casting Director's Book Hits #1 on Amazon Before Release
  • OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
  • Century Fasteners Corp. Exhibiting at the 2025 International Fastener Expo
  • JKS Financial Strengthens Regional Presence with New Office in Sewickley
  • Donors Join Forces to Support Center for Microbial Medicine at Children's Hospital of Philadelphia
  • Canvas Cloud AI Launches to Transform Cloud Education From Memorization to Mastery
  • The Squires Group Becomes a Workday Partner
  • From Vernon Hills to Mensa Before Kindergarten
  • Benchmark International Faciltd the Trans Between Total Sales & Marketing Inc and Retail Rex Capital
  • PermianMuseum.com adds Interstellar Visitor Video Gallery
  • SOBREO Elixirs Debut in New York City, Defining a New Era in Inclusive Hospitality

Popular on PennZone

  • LATO AI Transforms Operations, Facilitates Expansion for Leading Stone Fabricator - 152
  • ImagineX Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies - 151
  • ASI Showcasing Constituent Engagement Solutions at ASAE Annual Meeting & Spotlighting iMIS® Partner Marketplace - 149
  • DARA Abrams NYC Stories Art Experience at One Art Space - 145
  • Vitanergy Health US Inc. Launches Three New Dietary Supplements to Support Women's Daily Wellness - 145
  • HVAC Company Discusses Changes to Tax Credits with One Big Beautiful Bill - 144
  • $100 Million Raise Initiative Launched via Share Offering at $4 Level for Cryptocurrency and Real Estate Development Project Company: OFA Group $OFAL - 140
  • Jones Sports Announces Enhanced Leadership - 131
  • Assent Joins AWS ISV Accelerate Program - 120
  • Modernizing Pole Data Collection for Next-Gen Network Expansion - 118

Similar on PennZone

  • The Learning Circle Childcare Centre – South Surrey Campus Currently Enrolling for September & Fall
  • DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating data privacy Claims on Behalf of TransUnion Customers
  • New Leadership Model – Never Fire Anyone – Released Today
  • IOTAP Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
  • DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Healthcare Services Group, Inc. Customers Whose Data May Have Been Compromised
  • $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
  • DEADLINE TOMORROW: Berger Montague Advises Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) Investors to Inquire About a Securities Fraud Class Action by August 29, 2025
  • Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
  • OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
  • Donors Join Forces to Support Center for Microbial Medicine at Children's Hospital of Philadelphia
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us